Prediction of multiple sclerosis outcomes when switching to ocrelizumab. Zhong M, van der Walt A, Stankovich J, Kalincik T, et al. Mult Scler 2021 Oct 8:13524585211049986. doi: 10.1177/13524585211049986.

Read + Share

Amedeo Smart

Independent Medical Education

Zhong M, van der Walt A, Stankovich J, Kalincik T, et al. Prediction of multiple sclerosis outcomes when switching to ocrelizumab. Mult Scler 2021 Oct 8:13524585211049986. doi: 10.1177/13524585211049986.
PMID: 34623947